Author Contributions Conceived and designed the experiments: SSS YAA DMA AA. Performed the experiments: SSS YAA DMA CFA SG C-JJL DQ. Analyzed the data: References 1. Liu MA (2010) Immunologic basis of vaccine vectors. Immunity 33: 504–515. 2. Coffman RL, Sher A, Seder RA (2010) Vaccine adjuvants: putting innate immunity to work. Immunity 33: 492–503. 3. Williamson ED, Titball RW (2002) Vaccines against dangerous pathogens. Br Med Bull 62: 163–173. 4. Mbow ML, De Gregorio E, Valiante NM, Rappuoli R (2010) New adjuvants for human vaccines. Curr Opin Immunol 22: 411–416. 5. Hawlisch H, Kohl J (2006) Complement and Toll-like receptors: key regulators of adaptive immune responses. Mol Immunol 43: 13–21. 6. Iwasaki A, Medzhitov R (2004) Toll-like receptor control of the adaptive immune responses. Nat Immunol 5: 987–995. 7. Hedhli D, Dimier-Poisson I, Judge JW, Rosenberg B, Mevelec MN (2009) Protective immunity against Toxoplasma challenge in mice by coadministration of T. gondii antigens and Eimeria profilin-like protein as an adjuvant. Vaccine 27: 2274–2281. 8. Rosenberg B, Juckett DA, Aylsworth CF, Dimitrov NV, Ho SC, et al. (2005) Protein from intestinal Eimeria protozoan stimulates IL-12 release from dendritic cells, exhibits antitumor properties in vivo and is correlated with low intestinal tumorigenicity. Int J Cancer 114: 756–765. 9. Gowen BB, Smee DF, Wong MH, Judge JW, Jung KH, et al. (2006) Recombinant Eimeria protozoan protein elicits resistance to acute phlebovirus infection in mice but not hamsters. Antimicrob Agents Chemother 50: 2023–2029. 10. Juckett DA, Aylsworth CF, Quensen JM (2008) Intestinal protozoa are hypothesized to stimulate immunosurveillance against colon cancer. Med Hypotheses 71: 104–110. 11. Appledorn DM, Aldhamen YA, Depas W, Seregin SS, Liu CJ, et al. (2010) A new adenovirus based vaccine vector expressing an Eimeria tenella derived TLR agonist improves cellular immune responses to an antigenic target. PLoS One 5: e9579. 12. Appledorn DM, Aldhamen YA, Godbehere S, Seregin SS, Amalfitano A (2010) Sublingual administration of an Adenovirus based vaccine confirms TLR agonist activity in the oral cavity and elicits improved mucosal and systemic cell mediated responses against HIV antigens despite pre-existing Ad5 immunity. Clin Vaccine Immunol. 13. Rader JS, Aylsworth CF, Juckett DA, Mutch DG, Powell MA, et al. (2008) Phase I study and preliminary pharmacology of the novel innate immune modulator rBBX-01 in gynecologic cancers. Clin Cancer Res 14: 3089–3097. 14. Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, et al. (2005) TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308: 1626–1629. 15. Hartman ZC, Kiang A, Everett RS, Serra D, Yang XY, et al. (2007) Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo. J Virol 81: 1796–1812. 16. Blanco P, Palucka AK, Pascual V, Banchereau J (2008) Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev 19: 41–52. 17. Lee MS, Kim YJ (2007) Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem 76: 447–480. 18. Morefield GL, Sokolovska A, Jiang D, HogenEsch H, Robinson JP, et al. (2005) Role of aluminum-containing adjuvants in antigen internalization by dendritic cells in vitro. Vaccine 23: 1588–1595. 19. Hem SL, Hogenesch H (2007) Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation. Expert Rev Vaccines 6: 685–698. 20. Tritto E, Mosca F, De Gregorio E (2009) Mechanism of action of licensed vaccine adjuvants. Vaccine 27: 3331–3334. 21. Lambrecht BN, Kool M, Willart MA, Hammad H (2009) Mechanism of action of clinically approved adjuvants. Curr Opin Immunol 21: 23–29. 22. Laurent F, Bourdieu C, Kazanji M, Yvore P, Pery P (1994) The immunodominant Eimeria acervulina sporozoite antigen previously described as p160/p240 is a 19-kilodalton antigen present in several Eimeria species. Mol Biochem Parasitol 63: 79–86. TRIF Can Be a Suppressor of TLR Signaling SSS YAA DMA AA. Contributed reagents/materials/analysis tools: SSS YAA DMA CFA SG AA. Wrote the paper: SSS YAA AA. 23. Jenkins MC, Lillehoj HS, Dame JB (1988) Eimeria acervulina: DNA cloning and characterization of recombinant sporozoite and merozoite antigens. Exp Parasitol 66: 96–107. 24. Boonstra A, Rajsbaum R, Holman M, Marques R, Asselin-Paturel C, et al. (2006) Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals. J Immunol 177: 7551–7558. 25. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, et al. (2003) Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301: 640–643. 26. Kumar H, Kawai T, Akira S (2009) Toll-like receptors and innate immunity. Biochem Biophys Res Commun 388: 621–625. 27. Power MR, Li B, Yamamoto M, Akira S, Lin TJ (2007) A role of Toll-IL-1 receptor domain-containing adaptor-inducing IFN-beta in the host response to Pseudomonas aeruginosa lung infection in mice. J Immunol 178: 3170–3176. 28. Kumar H, Koyama S, Ishii KJ, Kawai T, Akira S (2008) Cutting edge: cooperation of IPS-1- and TRIF-dependent pathways in poly IC-enhanced antibody production and cytotoxic T cell responses. J Immunol 180: 683–687. 29. McAleer JP, Rossi RJ, Vella AT (2009) Lipopolysaccharide potentiates effector T cell accumulation into nonlymphoid tissues through TRIF. J Immunol 182: 5322–5330. 30. Hoebe K, Janssen EM, Kim SO, Alexopoulou L, Flavell RA, et al. (2003) Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent path- ways. Nat Immunol 4: 1223–1229. 31. Appledorn DM, Patial S, Godbehere S, Parameswaran N, Amalfitano A (2009) TRIF, and TRIF-Interacting TLRs Differentially Modulate Several Adenovirus Vector-Induced Immune Responses. J Inn Imm 1: 376–388. 32. Choi YJ, Im E, Pothoulakis C, Rhee SH (2010) TRIF modulates TLR5- dependent responses by inducing proteolytic degradation of TLR5. J Biol Chem 285: 21382–21390. 33. Kenny EF, O’Neill LA (2008) Signalling adaptors used by Toll-like receptors: an update. Cytokine 43: 342–349. 34. Biswas SK, Bist P, Dhillon MK, Kajiji T, Del Fresno C, et al. (2007) Role for MyD88-independent, TRIF pathway in lipid A/TLR4-induced endotoxin tolerance. J Immunol 179: 4083–4092. 35. Kawai T, Akira S (2007) TLR signaling. Semin Immunol 19: 24–32. 36. Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, et al. (2010) Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med 363: 411–422. 37. Conroy H, Marshall NA, Mills KH (2008) TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours. Oncogene 27: 168–180. 38. Seregin SS, Appledorn DM, McBride AJ, Schuldt NJ, Aldhamen YA, et al. (2009) Transient pretreatment with glucocorticoid ablates innate toxicity of systemically delivered adenoviral vectors without reducing efficacy. Mol Ther 17: 685–696. 39. Seregin SS, Aldhamen YA, Appledorn DM, Hartman ZC, Schuldt NJ, et al. (2010) Adenovirus capsid-display of the retro-oriented human complement inhibitor DAF reduces Ad vector-triggered immune responses in vitro and in vivo. Blood 116: 1669–1677. 40. Loniewski KJ, Patial S, Parameswaran N (2007) Sensitivity of TLR4- and -7- induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated- factor-6 revealed by RNAi in mouse macrophages. Mol Immunol 44: 3715–3723. 41. Parameswaran N, Pao CS, Leonhard KS, Kang DS, Kratz M, et al. (2006) Arrestin-2 and G protein-coupled receptor kinase 5 interact with NFkappaB1 p105 and negatively regulate lipopolysaccharide-stimulated ERK1/2 activation in macrophages. J Biol Chem 281: 34159–34170. 42. Appledorn DM, Patial S, McBride A, Godbehere S, Van Rooijen N, et al. (2008) Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo. J Immunol 181: 2134–2144. PLoS ONE | www.plosone.org 15 July 2011 | Volume 6 | Issue 7 | e22064